In support of our hypothesis, VRK1 inhibition sensitized ESCC cells to CDDP both in vitro and in vivo; conversely, reconstituting VRK1 made cells refractory to CDDP in vitro and in vivo. Here, VRK1 is linked to esophageal squamous cell carcinoma.